Medicine – Vestibulocochlear Nerve (Cranial Nerve VIII): Rinne’s and Weber’s Tests

The vestibulocochlear nerve, cranial nerve VIII, has two main components:

Cochlear division → hearing.

Vestibular division → balance.

Bedside assessment of hearing commonly includes Rinne’s test and Weber’s test, both performed with a tuning fork, typically 512 Hz.

1. Rinne’s Test

Rinne’s test compares air conduction (AC) with bone conduction (BC) in each ear separately.

Normally, sound is transmitted more efficiently through the external auditory canal and middle ear than through direct vibration of the skull.

Therefore, in a normal ear:

Air conduction > bone conduction.

This is called Rinne positive.

2. Normal Rinne Test

In a normal ear:

AC > BC.

The patient hears the tuning fork longer or louder when it is held beside the ear than when it is placed on the mastoid process.

This is a normal finding.

3. Sensorineural Deafness and Rinne’s Test

In sensorineural hearing loss, both air and bone conduction are reduced because the cochlea or auditory nerve is impaired.

However, the normal relationship between the two pathways remains:

AC > BC.

Therefore, Rinne remains positive.

So:

Normal ear → Rinne positive.

Sensorineural deafness → Rinne positive.

The difference is that overall hearing is reduced in sensorineural loss.

4. Conductive Deafness and Rinne’s Test

In conductive hearing loss, sound transmission through the external or middle ear is impaired.

Bone conduction bypasses these structures and may therefore be heard better than air conduction.

Thus:

BC > AC.

This is called Rinne negative.

Therefore:

Conductive hearing loss → Rinne negative.

5. Rinne Test – Quick Note Form

Normal: AC > BC → Rinne positive.

Sensorineural hearing loss: AC > BC → Rinne positive, but hearing is reduced overall.

Conductive hearing loss: BC > AC → Rinne negative.

6. Weber’s Test

Weber’s test compares how sound is perceived between the two ears.

A vibrating tuning fork is placed in the midline, usually on the forehead or vertex of the skull.

The patient is asked whether the sound is heard:

Equally in both ears.

or

Louder in one ear.

7. Normal Weber Test

In a person with normal hearing, the sound is heard equally in both ears.

This is described as:

Weber does not lateralise.

8. Conductive Hearing Loss and Weber’s Test

In unilateral conductive hearing loss, Weber’s test lateralises to the affected ear.

So:

Conductive deafness → sound louder in the abnormal ear.

This may seem counterintuitive, but external environmental sounds are reduced in that ear, so bone-conducted sound is perceived relatively more strongly.

9. Sensorineural Hearing Loss and Weber’s Test

In unilateral sensorineural hearing loss, Weber’s test lateralises to the normal or better-hearing ear.

So:

Sensorineural deafness → sound louder in the opposite ear.

The affected cochlea or auditory nerve cannot perceive the bone-conducted vibration normally.

10. Meaning of Weber Lateralisation

If Weber’s test is heard louder on the right side, there are two main possibilities:

Right conductive hearing loss.

or

Left sensorineural hearing loss.

Similarly, if the sound is louder on the left:

Left conductive hearing loss.

or

Right sensorineural hearing loss.

This is why Weber should be interpreted together with Rinne’s test.

11. Combining Rinne and Weber

A useful bedside approach is to use both tests together.

If Weber lateralises to the right and Rinne is negative on the right:

Right conductive hearing loss.

If Weber lateralises to the right and Rinne remains positive on both sides:

Left sensorineural hearing loss is more likely.

12. Conductive Hearing Loss – Typical Pattern

In unilateral conductive hearing loss:

Rinne on affected side → negative, BC > AC.

Weber → lateralises to affected side.

Example:

Right conductive deafness → right Rinne negative + Weber louder on right.

13. Sensorineural Hearing Loss – Typical Pattern

In unilateral sensorineural hearing loss:

Rinne → positive on both sides, AC > BC.

Weber → lateralises to the better-hearing ear.

Example:

Right sensorineural deafness → Rinne positive bilaterally + Weber louder on left.

14. Important Limitation of Rinne’s Test

In very severe unilateral sensorineural deafness, a false-negative Rinne test may occasionally occur.

This happens because bone-conducted vibration placed on the mastoid of the deaf ear may cross the skull and be heard by the opposite normal cochlea.

Therefore, bedside tuning-fork tests are useful screening tools but do not replace formal audiometry when significant hearing loss is suspected.

15. Vestibulocochlear Nerve – Note Form

Cranial nerve VIII: vestibulocochlear nerve.

Cochlear division: hearing.

Vestibular division: balance.

Rinne test: compares air conduction with bone conduction.

Normal Rinne: AC > BC.

Sensorineural loss: AC > BC, so Rinne remains positive.

Conductive loss: BC > AC, so Rinne is negative.

Weber test: tuning fork placed in middle of forehead or vertex.

Normal Weber: sound heard equally on both sides.

Conductive loss: Weber lateralises to the affected ear.

Sensorineural loss: Weber lateralises to the normal/better ear.

Key Clinical Pattern

Remember:

Rinne = compare AIR with BONE.

Weber = compare RIGHT with LEFT.

Normal:

Rinne positive (AC > BC)

Weber central

Conductive hearing loss:

Rinne negative on affected side (BC > AC)

Weber goes TO the affected ear

Sensorineural hearing loss:

Rinne positive (AC > BC)

Weber goes AWAY from the affected ear

Easy Memory Rule

Conductive → Weber goes TO the bad ear.

Sensorineural → Weber goes to the GOOD ear.

Medicine – Causes of Deafness

Deafness, or hearing loss, can be broadly divided into conductive hearing loss and sensorineural hearing loss. Conductive hearing loss occurs when sound cannot be transmitted efficiently through the external or middle ear, whereas sensorineural hearing loss results from damage to the cochlea, the vestibulocochlear nerve, or central auditory pathways.

An asterisk (*) below signifies a common cause.

1. Conductive Hearing Loss

Conductive hearing loss occurs when sound transmission through the external auditory canal, tympanic membrane, or middle-ear ossicles is impaired.

The cochlea and auditory nerve may remain functionally intact.

Typical causes include ear wax and middle-ear disease.

2. Ear Wax*

Impacted cerumen, or ear wax, is a common and usually reversible cause of conductive hearing loss.

Wax may obstruct the external auditory canal and prevent sound waves from reaching the tympanic membrane effectively.

Patients may complain of:

Reduced hearing.

Blocked-ear sensation.

Tinnitus.

Occasionally discomfort may occur.

Removal of the impacted wax usually restores hearing if no additional pathology is present.

3. Middle-Ear Disease*

Middle-ear disease is another common cause of conductive hearing loss.

Sound transmission may be impaired by fluid, infection, tympanic membrane abnormalities, or ossicular dysfunction.

Important examples include:

Otitis media.

Otitis media with effusion, or glue ear.

Tympanic membrane perforation.

Cholesteatoma.

Ossicular fixation or disruption.

The exact degree of hearing loss depends on the extent of mechanical impairment.

4. Sensorineural Hearing Loss

Sensorineural hearing loss results from damage to the inner ear, particularly the cochlea, or from dysfunction of the vestibulocochlear nerve and central auditory pathways.

Unlike many conductive causes, sensorineural hearing loss is often permanent.

It may be divided broadly into:

Cochlear causes.

Nerve or retrocochlear causes.

Congenital causes.

5. Cochlear Causes

Cochlear hearing loss results from damage to structures within the inner ear.

Important causes include:

Otosclerosis.

Noise-induced hearing loss.

Drug-induced ototoxicity.

Ménière disease.

Paget disease.

6. Otosclerosis*

Otosclerosis is caused by abnormal bone remodelling around the stapes and otic capsule.

Classically, fixation of the stapes footplate causes conductive hearing loss rather than purely sensorineural hearing loss.

However, if the disease extends into the cochlea, a sensorineural component may develop.

Therefore, although older notes may place otosclerosis under cochlear sensorineural causes, the classic presentation is:

Stapes fixation → conductive hearing loss.

7. Noise-Induced Hearing Loss*

Noise-induced hearing loss is a common cause of sensorineural deafness.

Prolonged or repeated exposure to loud noise damages cochlear hair cells.

Examples include:

Industrial noise.

Loud music.

Firearms.

Heavy machinery.

The hearing loss is usually bilateral and commonly affects high frequencies first.

8. Drug-Induced Hearing Loss

A number of drugs and toxins are ototoxic and may damage the cochlea or vestibular apparatus.

Important examples include:

Aminoglycoside antibiotics, such as gentamicin.

Loop diuretics, such as furosemide.

Certain chemotherapy drugs, especially cisplatin.

The original note also lists lead, which is better considered a toxic heavy-metal exposure rather than a drug.

9. Aminoglycosides

Aminoglycosides can damage cochlear and vestibular hair cells.

Examples include:

Gentamicin.

Amikacin.

Streptomycin.

Risk increases with higher cumulative exposure, renal impairment, and concurrent use of other ototoxic drugs.

Hearing loss may be permanent.

10. Furosemide

Furosemide is a loop diuretic that can cause ototoxicity, particularly when given in high doses or rapidly intravenously.

The risk may increase when combined with other ototoxic medications.

Hearing impairment may be reversible or permanent depending on severity.

11. Lead Exposure

Lead toxicity can damage the nervous system and may contribute to hearing impairment.

Lead is therefore best remembered as a toxic environmental cause rather than a conventional drug-induced cause.

12. Ménière Disease

Ménière disease causes fluctuating sensorineural hearing loss due to abnormal inner-ear fluid regulation, classically associated with endolymphatic hydrops.

The characteristic clinical combination is:

Episodic vertigo.

Fluctuating sensorineural hearing loss.

Tinnitus.

Aural fullness.

Hearing loss may become progressively permanent after repeated attacks.

13. Paget Disease

Paget disease of bone can involve the skull and temporal bone.

Abnormal bone remodelling may interfere with the auditory apparatus and produce:

Conductive hearing loss.

Sensorineural hearing loss.

or

Mixed hearing loss.

Therefore, hearing impairment in Paget disease is not exclusively cochlear.

14. Nerve or Retrocochlear Causes

Hearing loss may also result from damage to the vestibulocochlear nerve, CN VIII, or nearby central auditory pathways.

Important causes include:

Vestibular schwannoma.

Head trauma.

Meningitis.

15. Acoustic Neuroma

The traditional term acoustic neuroma usually refers to a vestibular schwannoma.

This is a benign tumour arising from Schwann cells, most commonly from the vestibular division of cranial nerve VIII.

A typical presentation is:

Progressive unilateral sensorineural hearing loss.

Unilateral tinnitus.

Imbalance.

Large tumours may also compress neighbouring cranial nerves or the brainstem.

16. Head Trauma

Head trauma can cause hearing loss by damaging:

The cochlea.

The vestibulocochlear nerve.

The temporal bone.

Central auditory pathways.

Temporal bone fractures may produce conductive, sensorineural, or mixed hearing loss depending on the structures damaged.

17. Meningitis

Meningitis is an important cause of acquired sensorineural hearing loss.

Inflammation can damage the cochlea or vestibulocochlear nerve.

Hearing impairment may be:

Unilateral or bilateral.

Temporary or permanent.

Bacterial meningitis is particularly important because severe hearing loss may occur after recovery from the acute infection.

18. Congenital Hearing Loss

Congenital hearing loss is present at birth or develops very early in life.

It may be caused by:

Genetic disorders.

Congenital infections.

Structural abnormalities of the inner ear.

Prematurity or perinatal complications.

Genetic causes account for a large proportion of congenital sensorineural hearing loss.

19. Congenital Infections

Important congenital infections associated with sensorineural hearing loss include:

Cytomegalovirus.

Rubella.

Other congenital infections can also cause auditory damage depending on the clinical context.

Early detection is essential because hearing impairment can significantly affect speech and language development.

20. Causes of Deafness – Note Form

Conductive hearing loss: impaired sound transmission through the external or middle ear.

Ear wax:* common, reversible obstruction of the external auditory canal.

Middle-ear disease:* otitis media, glue ear, tympanic membrane disease, cholesteatoma, or ossicular dysfunction.

Sensorineural hearing loss: damage to the cochlea, auditory nerve, or central auditory pathways.

Otosclerosis:* classically causes conductive hearing loss due to stapes fixation; cochlear involvement may add a sensorineural component.

Noise-induced hearing loss:* cochlear hair-cell damage from prolonged loud-noise exposure.

Drug-induced: aminoglycosides and furosemide are important ototoxic drugs.

Lead: toxic heavy-metal exposure that may contribute to hearing impairment.

Ménière disease: vertigo + fluctuating sensorineural hearing loss + tinnitus + aural fullness.

Paget disease: may produce conductive, sensorineural, or mixed hearing loss.

Acoustic neuroma: more accurately vestibular schwannoma; usually causes progressive unilateral sensorineural hearing loss and tinnitus.

Head trauma: may damage the cochlea, CN VIII, temporal bone, or central auditory pathways.

Meningitis: important acquired cause of sensorineural deafness, particularly after bacterial meningitis.

Congenital: genetic disorders, congenital infections, structural abnormalities, and perinatal causes.

Key Clinical Pattern

Remember the first division as:

Conductive deafness → external or middle-ear problem.

Sensorineural deafness → cochlea or auditory nerve problem.

The common conductive causes are:

Ear wax + middle-ear disease.

The major sensorineural causes to remember are:

Noise exposure + ototoxic drugs + Ménière disease + vestibular schwannoma + meningitis + congenital causes.

A particularly useful correction is:

Otosclerosis classically causes conductive hearing loss because of stapes fixation, although advanced cochlear involvement can produce a sensorineural component.

Medicine – Causes of Vertigo

Vertigo is the false sensation that the patient or surroundings are moving, usually described as spinning, tilting, or rotating. It results from dysfunction of the vestibular system and is broadly divided into peripheral vertigo, arising from the inner ear or vestibular nerve, and central vertigo, arising from the brainstem or cerebellar pathways.

A useful first step is:

Peripheral vertigo → inner ear/vestibular apparatus.

Central vertigo → brainstem or cerebellum.

1. Peripheral Vertigo

Peripheral vertigo results from disease affecting the labyrinth, semicircular canals, vestibular apparatus, or vestibular nerve.

It is often associated with:

Severe spinning sensation.

Nausea and vomiting.

Positional worsening.

Horizontal or rotatory nystagmus.

Depending on the cause, hearing loss or tinnitus may also occur.

2. Viral Vestibular Disease

A common peripheral cause is viral vestibular neuritis.

This typically presents with:

Acute severe vertigo.

Nausea and vomiting.

Unsteadiness.

No major hearing loss.

Symptoms may persist for hours to days.

The disorder is thought to involve inflammation of the vestibular nerve, often following or associated with a viral illness.

3. Labyrinthitis

If acute vertigo occurs together with hearing loss, the diagnosis may be labyrinthitis rather than isolated vestibular neuritis.

This distinction is useful:

Vestibular neuritis → vertigo without significant hearing loss.

Labyrinthitis → vertigo + hearing impairment.

4. Ménière Disease

Ménière disease is an important peripheral cause of recurrent vertigo.

The classical pattern is:

Episodic vertigo.

Fluctuating sensorineural hearing loss.

Tinnitus.

Aural fullness or pressure.

The condition is associated with abnormal regulation of endolymph within the inner ear.

5. Benign Paroxysmal Positional Vertigo

Benign paroxysmal positional vertigo (BPPV) is one of the most common causes of peripheral vertigo.

It produces brief episodes of vertigo triggered by changes in head position, such as:

Turning over in bed.

Looking upward.

Getting out of bed.

Bending down.

Episodes usually last seconds rather than hours.

6. Mechanism of BPPV

BPPV is usually caused by displaced otoconia entering a semicircular canal, most commonly the posterior canal.

Head movement causes abnormal movement of these particles, stimulating the vestibular system and producing vertigo.

Therefore:

Displaced otoconia → abnormal semicircular canal stimulation → positional vertigo.

7. Chronic Otitis Media

Chronic middle-ear disease can occasionally cause vertigo, particularly when infection or inflammation extends toward the labyrinth or produces complications.

Therefore, chronic otitis media can be associated with peripheral vertigo, but uncomplicated otitis media itself is not among the most typical causes of isolated vertigo.

8. Internal Auditory Artery Occlusion

Occlusion of the internal auditory artery, also called the labyrinthine artery, can cause sudden vestibular dysfunction.

Patients may develop:

Sudden severe vertigo.

Sudden sensorineural hearing loss.

This is important because vascular inner-ear disease can resemble other peripheral vestibular disorders.

9. Central Vertigo

Central vertigo results from disease affecting the brainstem, cerebellum, or central vestibular pathways.

It is especially important because some causes are potentially life-threatening.

Central vertigo may be associated with other neurological abnormalities such as:

Diplopia.

Dysarthria.

Limb weakness.

Sensory loss.

Severe ataxia.

Cranial nerve abnormalities.

10. Stroke

Stroke is one of the most important central causes of acute vertigo.

Posterior-circulation ischaemia involving the:

Brainstem.

Cerebellum.

can present with vertigo and imbalance.

A stroke should be considered particularly when vertigo is associated with new focal neurological findings or severe inability to stand or walk.

11. Posterior Circulation Stroke

Cerebellar or brainstem infarction may produce:

Sudden vertigo.

Nystagmus.

Vomiting.

Severe gait or truncal ataxia.

Additional symptoms may include:

Diplopia.

Dysarthria.

Dysphagia.

Weakness or sensory disturbance.

The absence of obvious limb weakness does not completely exclude a posterior-circulation stroke.

12. Alcohol

Acute alcohol intoxication can disturb cerebellar and vestibular function.

This may cause:

Dizziness or vertigo.

Nystagmus.

Ataxia.

Poor coordination.

Therefore, alcohol is an important toxic/metabolic contributor to central vestibular symptoms.

13. Drugs

Several medications can produce dizziness, vertigo, ataxia, or vestibular toxicity.

Examples include some:

Anticonvulsants.

Sedatives.

Aminoglycoside antibiotics.

Certain chemotherapy agents.

A careful medication history is therefore important in a patient presenting with vertigo.

14. Multiple Sclerosis

Multiple sclerosis can produce central vertigo when demyelinating plaques involve the brainstem or cerebellar vestibular pathways.

Other features suggesting MS may include:

Optic neuritis.

Diplopia.

Internuclear ophthalmoplegia.

Sensory symptoms.

Upper motor neurone signs.

Ataxia.

15. Space-Occupying Lesion

A space-occupying lesion, such as a tumour affecting the brainstem or cerebellum, can produce vertigo.

Examples include:

Glioma.

Cerebellar tumour.

Posterior-fossa mass.

Symptoms may be gradual and progressive rather than suddenly episodic.

16. Migraine

Vestibular migraine is an important and relatively common cause of recurrent vertigo.

Vertigo may occur:

With headache.

Before headache.

Without headache during some attacks.

Patients may also have typical migraine features such as photophobia, phonophobia, visual aura, or a previous migraine history.

17. Hypoglycaemia

Hypoglycaemia can cause dizziness, weakness, confusion, and unsteadiness.

True rotational vertigo is less specific, but hypoglycaemia should be considered in an acutely unwell patient with neurological or autonomic symptoms.

Associated features may include:

Sweating.

Tremor.

Palpitations.

Confusion.

Reduced consciousness.

18. Peripheral Vertigo – Note Form

BPPV: brief positional attacks, typically seconds, triggered by head movement.

Vestibular neuritis: acute prolonged vertigo, usually without hearing loss.

Labyrinthitis: vertigo with hearing impairment.

Ménière disease: episodic vertigo + fluctuating hearing loss + tinnitus + aural fullness.

Chronic otitis media: may cause vertigo when complicated by inner-ear involvement.

Internal auditory/labyrinthine artery occlusion: sudden vertigo often with sudden hearing loss.

19. Central Vertigo – Note Form

Stroke: sudden vertigo with possible brainstem or cerebellar neurological signs.

Alcohol: intoxication may cause vertigo, nystagmus and ataxia.

Drugs: sedative, anticonvulsant or vestibulotoxic medications can cause symptoms.

Multiple sclerosis: demyelinating brainstem or cerebellar lesions.

Space-occupying lesion: brainstem or cerebellar tumour, such as glioma.

Migraine: vestibular migraine causes recurrent vertigo, sometimes without headache.

Hypoglycaemia: metabolic cause of dizziness/unsteadiness and occasionally vertigo-like symptoms.

20. Peripheral versus Central Vertigo – Quick Note Form

Peripheral vertigo: usually more intense spinning and nausea.

Central vertigo: may be less intensely spinning but is more likely to have neurological signs.

Peripheral hearing symptoms: may occur, especially Ménière disease, labyrinthitis, or labyrinthine artery occlusion.

Central hearing symptoms: generally less typical, depending on lesion location.

Peripheral neurological deficits: usually absent.

Central neurological deficits: may include diplopia, dysarthria, weakness, sensory loss or marked ataxia.

Peripheral causes: BPPV, vestibular neuritis, labyrinthitis, Ménière disease.

Central causes: stroke, MS, migraine, tumours, drugs or toxins.

Key Clinical Pattern

The easiest way to remember the common causes is:

Peripheral vertigo → BPPV + vestibular neuritis/labyrinthitis + Ménière disease.

Central vertigo → stroke + MS + vestibular migraine + posterior-fossa lesions.

A very useful clinical clue is:

Vertigo + hearing symptoms → think peripheral inner-ear disease.

Vertigo + focal neurological signs or severe central ataxia → think central cause, especially posterior-circulation stroke.

Medicine – Bulbar Palsy vs Pseudobulbar Palsy

Bulbar palsy and pseudobulbar palsy can both cause dysarthria and dysphagia, but they arise from lesions at different levels of the motor pathway. The simplest distinction is that bulbar palsy is a lower motor neurone (LMN) disorder, whereas pseudobulbar palsy is a bilateral upper motor neurone (UMN) corticobulbar disorder.

1. Site of Lesion

Bulbar palsy: The lesion affects the motor cranial nerve nuclei in the medulla or their peripheral nerves, particularly pathways involving cranial nerves IX, X and XII.

Pseudobulbar palsy: The lesion is above the cranial nerve nuclei and affects the corticobulbar tracts bilaterally.

Therefore:

Bulbar = cranial nerve nuclei/nerves → LMN.

Pseudobulbar = bilateral corticobulbar tracts → UMN.

2. Type of Motor Neurone Lesion

Bulbar palsy: Lower motor neurone lesion.

Because LMNs are damaged, the affected muscles become weak and may undergo atrophy and fasciculation.

Pseudobulbar palsy: Upper motor neurone lesion.

Loss of descending cortical control produces spasticity and exaggerated reflexes rather than prominent muscle wasting and fasciculations.

3. Cranial Nerve Functions Affected

Both conditions particularly interfere with functions mediated through:

CN IX – glossopharyngeal nerve.

CN X – vagus nerve.

CN XII – hypoglossal nerve.

However, pseudobulbar palsy is better considered a bilateral corticobulbar syndrome, so facial and jaw movements may also be affected.

4. Tongue in Bulbar Palsy

The tongue in bulbar palsy is characteristically:

Weak.

Wasted or atrophied.

Fasciculating.

Movement of the tongue may be markedly reduced.

The combination of tongue wasting + fasciculations is a classic clue to LMN involvement.

5. Tongue in Pseudobulbar Palsy

The tongue in pseudobulbar palsy is:

Stiff.

Spastic.

Slow-moving.

There are generally no prominent fasciculations because the lower motor neurones themselves remain intact.

Therefore:

Wasted + fasciculating tongue → bulbar palsy.

Spastic tongue without fasciculations → pseudobulbar palsy.

6. Dysarthria

Both disorders can produce dysarthria, but the character of the speech differs.

Bulbar palsy: Speech is flaccid, weak, slurred and often nasal because of weakness of the tongue, palate, pharynx and larynx.

Pseudobulbar palsy: Speech is typically slow, strained and spastic. Older textbooks sometimes describe this as “Donald Duck speech.”

7. Dysphagia

Dysphagia can occur in both conditions.

In bulbar palsy, weakness of the palate, pharynx and larynx can cause:

Choking.

Coughing during meals.

Nasal regurgitation of fluids.

Aspiration.

In pseudobulbar palsy, swallowing is impaired because voluntary control of the swallowing musculature is disrupted by bilateral corticobulbar damage.

Both conditions can therefore cause clinically important aspiration.

8. Nasal Regurgitation

Bulbar palsy: Nasal regurgitation is particularly characteristic because weakness of the soft palate prevents adequate closure of the nasopharynx during swallowing.

Pseudobulbar palsy: Dysphagia occurs, but the classical picture is dominated more by spastic swallowing dysfunction rather than flaccid palatal weakness.

9. Jaw Jerk

The jaw jerk is one of the most useful examination differences.

Bulbar palsy: The jaw jerk is not characteristically exaggerated and may be reduced if the relevant LMN reflex pathway is involved.

Pseudobulbar palsy: The jaw jerk is brisk or exaggerated because of bilateral UMN corticobulbar damage.

Therefore:

Exaggerated jaw jerk → think pseudobulbar palsy.

10. Gag Reflex

Bulbar palsy: The gag reflex may be reduced or absent when the relevant IX/X lower motor pathways are affected.

Pseudobulbar palsy: Bulbar reflexes may be brisk or exaggerated because of loss of descending inhibitory control.

However, the gag reflex naturally varies between individuals, so it should not be interpreted alone.

11. Muscle Wasting

Bulbar palsy: Muscle wasting occurs because the lower motor neurones directly supplying the muscles are damaged.

Pseudobulbar palsy: Marked denervation wasting is not expected because the lower motor neurones remain intact.

This again follows the general rule:

LMN → wasting and fasciculations.

UMN → spasticity and hyperreflexia.

12. Fasciculations

Bulbar palsy: Fasciculations, particularly of the tongue, may be clearly visible.

Pseudobulbar palsy: Fasciculations are generally absent.

A wasted fasciculating tongue should therefore immediately suggest a lower motor neurone bulbar lesion.

13. Emotional Lability

Bulbar palsy: Emotional lability is not a characteristic consequence of the LMN lesion itself.

Pseudobulbar palsy: Emotional lability is characteristic.

The patient may have sudden episodes of uncontrollable:

Laughing.

or

Crying.

This is known as pseudobulbar affect.

14. Causes of Bulbar Palsy

Important causes include:

Motor neurone disease.

Guillain–Barré syndrome.

Other diseases affecting the medullary motor nuclei or lower cranial nerves can also produce bulbar weakness.

Motor neurone disease is particularly important because it may produce both LMN and UMN abnormalities.

15. Causes of Pseudobulbar Palsy

Important causes include:

Bilateral cerebrovascular disease, such as multiple strokes affecting the corticobulbar pathways.

Multiple sclerosis.

Motor neurone disease.

Other disorders producing bilateral corticobulbar tract damage can also cause the syndrome.

16. Motor Neurone Disease Can Cause Both

An important point is that motor neurone disease can produce both bulbar and pseudobulbar features.

This occurs because diseases such as ALS can damage both:

LMNs → bulbar palsy.

and

UMNs → pseudobulbar palsy.

Therefore, a patient with motor neurone disease may have mixed findings.

For example:

Tongue fasciculations → LMN involvement.

Brisk jaw jerk → UMN involvement.

Finding both suggests combined upper and lower motor neurone disease.

17. Bulbar Palsy – Quick Note Form

Lesion: LMN.

Site: cranial nerve nuclei/peripheral lower cranial nerves.

Important nerves: IX, X, XII.

Tongue: wasted, weak and fasciculating.

Speech: weak, flaccid and often nasal.

Swallowing: dysphagia.

Nasal regurgitation: common with palatal weakness.

Jaw jerk: not exaggerated.

Gag: may be reduced.

Emotional lability: not characteristic.

Main causes: motor neurone disease and Guillain–Barré syndrome.

18. Pseudobulbar Palsy – Quick Note Form

Lesion: UMN.

Site: bilateral corticobulbar tracts.

Tongue: stiff/spastic without prominent fasciculations.

Speech: slow, strained and spastic.

Swallowing: dysphagia.

Jaw jerk: exaggerated/brisk.

Bulbar reflexes: may be exaggerated.

Emotional lability: characteristic.

Main causes: bilateral cerebrovascular disease, multiple sclerosis and motor neurone disease.

19. Fastest Examination Distinction

When trying to distinguish the two at the bedside, look particularly at the tongue, jaw jerk and emotional response.

Bulbar palsy:

Wasted fasciculating tongue

↓

LMN

↓

Weak/flaccid speech + dysphagia

Pseudobulbar palsy:

Spastic tongue + brisk jaw jerk + emotional lability

↓

Bilateral UMN corticobulbar lesion

↓

Spastic speech + dysphagia

Key Clinical Differences

Bulbar palsy = LMN.

Pseudobulbar palsy = bilateral UMN.

Bulbar → tongue wasted and fasciculating.

Pseudobulbar → tongue spastic, no prominent fasciculations.

Bulbar → flaccid/nasal dysarthria.

Pseudobulbar → spastic/strained dysarthria.

Bulbar → jaw jerk not exaggerated.

Pseudobulbar → jaw jerk exaggerated.

Bulbar → gag may be reduced.

Pseudobulbar → reflexes may be brisk.

Bulbar → emotional lability not characteristic.

Pseudobulbar → emotional lability characteristic.

Bulbar causes → MND + Guillain–Barré syndrome.

Pseudobulbar causes → bilateral strokes + MS + MND.

Key Clinical Pattern

The easiest memory rule is:

BULBAR = LMN = WASTING

PSEUDOBULBAR = UMN = SPASTICITY

So:

Wasted fasciculating tongue → Bulbar palsy.

Spastic tongue + brisk jaw jerk + emotional lability → Pseudobulbar palsy.

Medicine – Bulbar Palsy

Bulbar palsy is a lower motor neurone (LMN) syndrome caused by dysfunction of the motor cranial nerve nuclei in the medulla or their peripheral nerves. It primarily affects the muscles responsible for speech, swallowing, chewing, and tongue movement.

The most important cranial nerves involved are IX (glossopharyngeal), X (vagus), and XII (hypoglossal), although other lower cranial nerves may also be involved depending on the underlying disease.

1. Anatomical Basis

The term “bulbar” refers to the medulla oblongata, historically called the bulb.

The medulla contains important motor nuclei controlling the pharynx, larynx, and tongue. Damage to these nuclei or their peripheral axons produces lower motor neurone weakness of the bulbar muscles.

Therefore:

Cranial nerve nuclei/peripheral nerves damaged → LMN bulbar weakness → bulbar palsy.

2. Cranial Nerves Involved

The major cranial nerves involved are:

CN IX – glossopharyngeal nerve: contributes to pharyngeal sensation and swallowing.

CN X – vagus nerve: controls much of the palate, pharynx, and larynx.

CN XII – hypoglossal nerve: controls tongue movements.

In some disorders, CN XI and other cranial motor functions may also be affected.

3. Lower Motor Neurone Disorder

Bulbar palsy is fundamentally a lower motor neurone disorder.

This distinguishes it from pseudobulbar palsy, which results from bilateral upper motor neurone lesions affecting the corticobulbar pathways.

The LMN nature of bulbar palsy explains the characteristic:

Muscle weakness.

Muscle wasting.

Fasciculations.

Reduced reflex activity where the relevant reflex arc is affected.

4. Tongue Atrophy

Damage to the hypoglossal lower motor neurones causes weakness and atrophy of the tongue.

The tongue may appear:

Thin.

Wasted.

Wrinkled or furrowed.

Tongue movements become weak and poorly coordinated.

5. Tongue Fasciculations

Fasciculations are another characteristic LMN finding.

These are small, spontaneous contractions of individual motor units that may be visible beneath the surface of the tongue.

Therefore:

Wasted + fasciculating tongue → think LMN lesion → bulbar palsy.

This is particularly important when motor neurone disease is suspected.

6. Pharyngeal Weakness

Weakness of the pharyngeal muscles interferes with the normal swallowing mechanism.

Food or fluid may not be effectively propelled from the mouth and pharynx into the oesophagus.

This produces dysphagia and increases the risk of aspiration.

7. Laryngeal Weakness

Weakness of muscles supplied through the vagus nerve can impair laryngeal function.

The patient’s voice may become:

Weak.

Hoarse.

Breathy.

Speech may become increasingly difficult to understand.

Laryngeal weakness also reduces the patient’s ability to protect the airway effectively during swallowing.

8. Palatal Weakness

Weakness of the soft palate may result in poor closure of the nasopharynx during speech and swallowing.

This can produce:

Nasal speech.

Nasal regurgitation of liquids.

On examination, palatal movement may be reduced.

9. Dysarthria

Dysarthria is common because weakness affects the tongue, palate, pharynx, and larynx.

Speech in bulbar palsy is typically weak and flaccid, and it may have a nasal quality.

This contrasts with the strained, spastic dysarthria of pseudobulbar palsy.

10. Dysphagia

Dysphagia is one of the most clinically important manifestations.

Patients may have difficulty swallowing both food and liquids.

They may experience:

Choking during meals.

Coughing after swallowing.

Food sticking in the throat.

Nasal regurgitation of fluids.

Recurrent aspiration.

11. Nasal Regurgitation

Nasal regurgitation occurs because weakness of the soft palate prevents effective closure between the oropharynx and nasopharynx during swallowing.

As a result, particularly with liquids:

Swallowed fluid → enters nasopharynx → comes out through the nose.

This is a useful clinical clue to bulbar muscle weakness.

12. Aspiration

Failure of effective pharyngeal and laryngeal function can allow food, fluid, or saliva to enter the airway.

This may cause:

Choking episodes.

Aspiration pneumonia.

Recurrent chest infections.

Aspiration is one of the major complications of severe bulbar palsy.

13. Gag Reflex

The gag reflex may be reduced or absent when the relevant lower motor neurone pathways involving cranial nerves IX and X are damaged.

However, the gag reflex is naturally variable between individuals and should not be interpreted in isolation.

The overall pattern of bulbar weakness is more important.

14. Motor Neurone Disease

Motor neurone disease (MND) is an important cause of progressive bulbar palsy.

In amyotrophic lateral sclerosis, degeneration may affect both upper and lower motor neurones.

Bulbar LMN involvement can produce:

Tongue wasting.

Tongue fasciculations.

Dysarthria.

Dysphagia.

Weak cough.

15. Progressive Bulbar Palsy

Some patients with motor neurone disease initially present predominantly with progressive weakness of the bulbar muscles.

This clinical presentation has traditionally been called progressive bulbar palsy.

Over time, signs of motor neurone disease may become apparent elsewhere in the body.

16. Mixed Bulbar and Pseudobulbar Features in MND

Motor neurone disease can affect both:

Lower motor neurones → bulbar signs.

and

Upper motor neurones → pseudobulbar signs.

A patient may therefore demonstrate a mixture, such as tongue fasciculations together with a brisk jaw jerk.

This mixed UMN/LMN pattern is particularly important in ALS.

17. Guillain–Barré Syndrome

Guillain–Barré syndrome (GBS) can also cause bulbar palsy through involvement of peripheral cranial nerves.

Patients may develop:

Facial weakness.

Dysphagia.

Dysarthria.

Impaired airway protection.

Bulbar involvement is clinically important because it can accompany respiratory muscle weakness.

18. Respiratory Risk in Guillain–Barré Syndrome

A patient with GBS and bulbar weakness requires careful respiratory assessment.

Weakness of respiratory and bulbar muscles can lead to:

Aspiration.

Ineffective cough.

Retention of secretions.

Respiratory failure.

Severe cases require close monitoring and sometimes mechanical ventilation.

19. Other Causes of Bulbar Palsy

Although your notes emphasise MND and GBS, other lesions affecting the lower cranial nerve nuclei or nerves can produce a bulbar syndrome.

Examples include:

Brainstem infarction.

Brainstem tumours.

Poliomyelitis in relevant settings.

Other peripheral neuropathies affecting lower cranial nerves.

The exact pattern depends on the anatomical site involved.

20. Bulbar Palsy versus Pseudobulbar Palsy – Note Form

Bulbar palsy: lower motor neurone lesion.

Pseudobulbar palsy: bilateral upper motor neurone corticobulbar lesion.

Bulbar tongue: wasted and fasciculating.

Pseudobulbar tongue: stiff/spastic without prominent fasciculations.

Bulbar speech: weak, flaccid and often nasal.

Pseudobulbar speech: slow, strained and spastic.

Bulbar jaw jerk: usually not exaggerated.

Pseudobulbar jaw jerk: characteristically brisk/exaggerated.

Bulbar gag reflex: may be reduced or absent.

Pseudobulbar reflexes: may be exaggerated.

Bulbar emotional lability: not characteristic.

Pseudobulbar emotional lability: characteristic pseudobulbar affect may occur.

Bulbar main pathology: cranial nerve nuclei or peripheral lower cranial nerves.

Pseudobulbar main pathology: bilateral corticobulbar tracts.

21. Investigation

Investigation depends on the suspected underlying cause.

Possible investigations include:

MRI of the brain and brainstem when a structural lesion is suspected.

Nerve-conduction studies and EMG when motor neurone disease or peripheral neuropathy is considered.

CSF examination when an inflammatory neuropathy such as GBS is suspected.

In GBS, CSF classically demonstrates:

Raised protein + relatively few cells = albuminocytologic dissociation.

22. Management

Treatment is directed toward the underlying disorder, but supportive management of bulbar dysfunction is crucial.

This may involve:

Speech and language therapy.

Formal swallowing assessment.

Dietary modification.

Aspiration precautions.

Nutritional support.

Respiratory monitoring.

Severe dysphagia may eventually require enteral feeding, depending on the underlying condition and clinical circumstances.

23. Bulbar Palsy – Note Form

Type: lower motor neurone syndrome.

Main cranial nerves: IX, X and XII.

Tongue: atrophied, weak and fasciculating.

Pharynx: weak → dysphagia and choking.

Palate: weak → nasal speech and nasal regurgitation of liquids.

Larynx: weak → dysphonia/hoarse or weak voice and impaired airway protection.

Speech: flaccid dysarthria.

Swallowing: dysphagia with aspiration risk.

Reflexes: gag may be reduced; jaw jerk is not characteristically exaggerated.

Major cause: motor neurone disease.

Another important cause: Guillain–Barré syndrome.

Key Clinical Pattern

Remember bulbar palsy as:

LMN lesion of lower cranial motor pathways → dysarthria + dysphagia + nasal regurgitation + wasted fasciculating tongue.

The easiest distinction is:

Bulbar palsy = LMN → wasted fasciculating tongue + weak/flaccid speech.

Pseudobulbar palsy = UMN → spastic tongue + brisk jaw jerk + emotional lability.

For the causes in your notes, remember:

Motor neurone disease + Guillain–Barré syndrome → bulbar palsy.

Medicine – Pseudobulbar Palsy

Pseudobulbar palsy is an upper motor neurone (UMN) syndrome caused by bilateral damage to the corticobulbar pathways that control the muscles of speech, swallowing, chewing, and facial expression.

It resembles bulbar palsy clinically, but the underlying lesion is different. In pseudobulbar palsy the problem is supranuclear and bilateral, whereas true bulbar palsy results from lower motor neurone damage involving the cranial nerve nuclei or their peripheral nerves.

1. Anatomical Basis

The motor nuclei of the cranial nerves receive descending input from the motor cortex through the corticobulbar tracts.

Pseudobulbar palsy occurs when these corticobulbar pathways are damaged bilaterally.

The clinically important functions particularly involve pathways controlling cranial nerves:

IX – glossopharyngeal nerve.

X – vagus nerve.

XII – hypoglossal nerve.

However, pseudobulbar palsy is better understood as a bilateral corticobulbar syndrome rather than simply impairment of cranial nerves IX, X and XII, because facial and jaw movements can also be affected.

2. Why the Lesion Must Usually Be Bilateral

Most cranial motor nuclei receive substantial corticobulbar input from both cerebral hemispheres.

Consequently, a unilateral corticobulbar lesion often does not produce the full syndrome.

Significant pseudobulbar palsy usually develops after bilateral corticobulbar tract damage.

Therefore:

Bilateral UMN corticobulbar lesions → pseudobulbar palsy.

3. Dysarthria

Dysarthria is a prominent feature.

Because the muscles controlling speech are spastic and poorly coordinated, speech becomes:

Slow.

Strained.

Harsh.

Indistinct.

Older textbooks sometimes describe this as “Donald Duck speech.” This is a historical descriptive term; spastic dysarthria is the more useful clinical terminology.

4. Dysphagia

Difficulty swallowing, or dysphagia, is another important manifestation.

Patients may have difficulty coordinating the pharyngeal and laryngeal muscles required for safe swallowing.

This can lead to:

Choking.

Coughing during meals.

Aspiration.

Recurrent aspiration pneumonia.

Therefore, swallowing assessment is important in clinically significant pseudobulbar palsy.

5. Tongue Appearance

The tongue may appear small, stiff, and spastic, with impaired voluntary movement.

Because this is an upper motor neurone lesion, there is generally no prominent fasciculation.

This is an important distinction from true bulbar palsy.

6. Tongue in Pseudobulbar versus Bulbar Palsy

In pseudobulbar palsy:

Tongue → spastic and slow-moving, without prominent fasciculations.

In bulbar palsy:

Tongue → wasted, weak and may show fasciculations.

This distinction reflects the difference between UMN and LMN pathology.

7. Exaggerated Jaw Jerk

The jaw jerk is exaggerated or brisk in pseudobulbar palsy.

This occurs because bilateral corticobulbar damage removes normal descending inhibition of the trigeminal motor reflex pathway.

Therefore:

Brisk jaw jerk → UMN corticobulbar lesion → supports pseudobulbar palsy.

8. Other Exaggerated Reflexes

Other bulbar reflexes may also become exaggerated.

Patients may demonstrate:

Brisk gag reflex.

Exaggerated facial reflexes.

Pathological emotional responses.

These findings reflect loss of supranuclear inhibitory control.

9. Emotional Lability

A characteristic feature is emotional lability, also called pseudobulbar affect.

Patients may experience sudden, involuntary episodes of:

Crying.

Laughing.

These responses may be exaggerated, difficult to control, or inappropriate to the emotional context.

10. Pseudobulbar Affect

Pseudobulbar affect does not necessarily mean that the patient is genuinely feeling extremely sad or happy.

Instead, damage to neural pathways regulating emotional expression produces a mismatch between the patient’s internal emotional state and outward expression.

Thus:

Uncontrollable laughing or crying + bilateral corticobulbar disease → pseudobulbar affect.

11. Bilateral Cerebrovascular Disease

One of the classic causes of pseudobulbar palsy is bilateral cerebrovascular disease affecting the corticobulbar pathways.

The original note describes bilateral internal-capsule lesions as the most common cause.

Multiple strokes involving the internal capsules or other corticobulbar pathways can indeed produce the syndrome.

A single unilateral internal-capsule stroke usually does not produce the complete classical pseudobulbar syndrome.

12. Multiple Sclerosis

Multiple sclerosis can cause pseudobulbar palsy when demyelinating lesions affect corticobulbar pathways on both sides.

Other neurological findings suggesting MS may coexist, including:

Optic neuritis.

Upper motor neurone limb weakness.

Sensory abnormalities.

Internuclear ophthalmoplegia.

Ataxia.

Bladder dysfunction.

13. Motor Neurone Disease

Motor neurone disease, particularly amyotrophic lateral sclerosis, may involve corticobulbar upper motor neurone pathways.

Patients can therefore develop pseudobulbar features such as:

Spastic dysarthria.

Brisk jaw jerk.

Emotional lability.

However, motor neurone disease may involve both upper and lower motor neurones, so patients can develop a mixture of pseudobulbar and true bulbar signs.

14. Other Causes

Other bilateral cerebral disorders can also produce pseudobulbar palsy.

These include:

Traumatic brain injury.

Certain neurodegenerative diseases.

Bilateral cerebral tumours or structural lesions.

Other disorders producing bilateral corticobulbar tract damage.

The underlying principle is always the same:

Bilateral corticobulbar UMN damage → pseudobulbar palsy.

15. Bulbar Palsy

Bulbar palsy, by contrast, is a lower motor neurone syndrome involving the motor nuclei of the medulla or the corresponding cranial nerves.

It particularly affects cranial nerves IX, X, XI and XII, depending on the underlying disorder.

Patients develop dysarthria and dysphagia, just as in pseudobulbar palsy, but the examination findings are different.

16. Pseudobulbar Palsy versus Bulbar Palsy – Note Form

Pseudobulbar palsy: upper motor neurone disorder.

Bulbar palsy: lower motor neurone disorder.

Pseudobulbar lesion: bilateral corticobulbar tracts.

Bulbar lesion: cranial nerve nuclei or peripheral cranial nerves.

Pseudobulbar tongue: stiff/spastic, without prominent fasciculations.

Bulbar tongue: weak, wasted and fasciculating.

Pseudobulbar jaw jerk: brisk or exaggerated.

Bulbar jaw jerk: usually reduced or absent when the relevant LMN reflex arc is affected.

Pseudobulbar emotional lability: characteristic.

Bulbar emotional lability: not a characteristic LMN feature.

Pseudobulbar speech: spastic, strained dysarthria.

Bulbar speech: flaccid, weak dysarthria, often nasal depending on the muscles involved.

17. Clinical Assessment

Evaluation should determine the underlying cause of the bilateral corticobulbar dysfunction.

Depending on the presentation, investigations may include:

MRI or CT of the brain.

Assessment for previous or acute cerebrovascular disease.

MRI for demyelinating disease.

Neuromuscular assessment if motor neurone disease is suspected.

Swallowing and speech assessments are also important because aspiration and communication difficulties can significantly affect patients.

18. Management

Treatment is directed primarily toward the underlying neurological disease.

Supportive management may include:

Speech and language therapy.

Swallowing assessment.

Dietary modification.

Aspiration prevention.

Nutritional support when required.

Treatment of pseudobulbar affect when troublesome.

19. Pseudobulbar Palsy – Note Form

Type of lesion: upper motor neurone.

Anatomical lesion: bilateral corticobulbar pathways.

Important cranial functions affected: particularly those mediated through IX, X and XII, with additional facial and jaw involvement possible.

Speech: spastic dysarthria; historically described as “Donald Duck speech.”

Swallowing: dysphagia with aspiration risk.

Tongue: small/stiff and spastic, without the marked wasting and fasciculation of LMN bulbar palsy.

Jaw jerk: exaggerated.

Emotional feature: emotional lability or pseudobulbar affect with inappropriate/uncontrollable laughing or crying.

Cerebrovascular cause: bilateral corticobulbar damage from multiple strokes, including bilateral internal-capsule lesions.

Demyelinating cause: multiple sclerosis.

Motor neurone cause: motor neurone disease/ALS, which may produce mixed UMN and LMN bulbar findings.

Key Clinical Pattern

Remember pseudobulbar palsy as:

Bilateral corticobulbar UMN lesion → dysarthria + dysphagia + spastic tongue + brisk jaw jerk + emotional lability.

The easiest distinction is:

Pseudobulbar palsy = UMN → brisk jaw jerk + spastic tongue + emotional lability.

Bulbar palsy = LMN → wasted fasciculating tongue + reduced LMN reflexes.

And the major causes to remember are:

Bilateral cerebrovascular disease + multiple sclerosis + motor neurone disease.

Infectious Disease and Microbiology – Loa loa

Overview

Loa loa is a filarial nematode that causes loiasis, also known as African eye worm disease. Infection is endemic in parts of Central and West Africa and is transmitted to humans by the bite of infected Chrysops deer flies.

Most infected individuals remain asymptomatic. Symptomatic disease classically produces transient angioedematous swellings called Calabar swellings and migration of an adult worm across the subconjunctival tissues of the eye.

Classification

Genus: Loa

Species: Loa loa

Type: Filarial nematode

Disease: Loiasis

Common name: African eye worm

Microbiologic Characteristics

L. loa is a:

• Tissue-dwelling filarial nematode

• Parasite transmitted by an arthropod vector

• Cause of chronic subcutaneous infection

• Producer of circulating microfilariae

Adult worms migrate through the subcutaneous tissues, whereas microfilariae circulate in the peripheral bloodstream.

Vector

The vector is an infected:

Chrysops deer fly

These flies are also called:

Deer flies or mango flies

Transmission occurs when an infected fly takes a blood meal and introduces infective larvae into the skin.

Transmission Cycle

Infected Chrysops fly bites human

↓

Infective larvae enter the skin

↓

Larvae mature into adult worms

↓

Adult worms migrate through subcutaneous tissues

↓

Females release microfilariae

↓

Microfilariae circulate in peripheral blood

↓

Another deer fly ingests microfilariae

Incubation and Development

Microfilariae may become detectable in peripheral blood several months after infection.

The source describes approximately:

4 months

as an early point at which microfilaremia or symptoms may appear.

However, symptomatic loiasis frequently develops only after:

Several years

This prolonged course reflects the chronic nature of filarial infection.

Epidemiology

Loiasis occurs primarily in:

Central and West Africa

particularly in forested regions where the Chrysops vector is present.

The source estimates that millions of people may be infected in endemic regions.

Clinical Infection

The disease caused by L. loa is:

Loiasis

Most infected people are:

Asymptomatic

When manifestations occur, they primarily result from migration of adult worms through subcutaneous tissues and the host inflammatory response.

Calabar Swellings

Classic Manifestation

One of the most characteristic findings is:

Calabar swelling

These are transient, localized areas of subcutaneous edema caused by the inflammatory response associated with migrating adult worms.

Clinical Features

Calabar swellings may:

• Appear suddenly

• Occur on different parts of the body

• Produce localized discomfort

• Cause pruritus

• Cause localized pain

• Persist temporarily and then resolve

• Recur at another location

The extremities are commonly affected.

Pathogenesis

Adult worm migrates through tissue

↓

Local inflammatory/hypersensitivity response

↓

Transient localized edema

↓

Calabar swelling

Eye Worm

Subconjunctival Migration

Another classic manifestation is migration of an:

Adult Loa loa worm across the conjunctiva

The worm may be directly visible moving beneath the conjunctival surface.

This striking finding accounts for the name:

African eye worm

Clinical Manifestations

Subconjunctival migration can cause:

• Foreign-body sensation

• Eye irritation

• Conjunctival inflammation

• Lacrimation

• Discomfort

Although dramatic, the worm’s passage across the eye is usually transient.

High-Yield Clinical Pattern

Patient from Central or West Africa

• ●

Recurrent transient localized swelling

• ●

Visible worm migrating across the conjunctiva

→ Think Loa loa

→ Diagnosis: Loiasis

Microfilariae

Diurnal Periodicity

A particularly important characteristic is:

Diurnal periodicity

Loa loa microfilariae are most abundant in peripheral blood during the:

Daytime

This corresponds with the daytime feeding behavior of the Chrysops vector.

Diagnostic Implication

Blood should therefore be collected during:

Daylight hours

Traditionally, collection around the middle of the day improves the likelihood of detecting microfilariae.

This is a major examination clue.

Diagnosis

Peripheral Blood Smear

The classic diagnostic method is:

Detection of microfilariae in peripheral blood

Because of diurnal periodicity:

Obtain a daytime blood sample.

Thick and thin blood smears can be examined microscopically.

Direct Visualization

Diagnosis may also be established by:

Visualizing an adult worm beneath the conjunctiva

This is a highly characteristic finding in the appropriate epidemiologic setting.

Tissue Examination

The parasite may occasionally be identified in:

Subcutaneous tissue

especially when a migrating adult worm is removed.

Serology

The source also lists:

Serologic testing

Serology can support the diagnosis but may have limitations in distinguishing among filarial infections, particularly in endemic areas.

Treatment

Diethylcarbamazine

The source identifies:

Diethylcarbamazine (DEC)

as the principal treatment for loiasis.

DEC has activity against:

Microfilariae

and can also have activity against:

Adult worms

Therefore, it has the potential to provide definitive treatment.

Major Treatment Danger

High Microfilarial Burden

Treatment of loiasis requires special caution because rapid killing of large numbers of microfilariae can provoke a severe inflammatory reaction.

This is particularly important in patients with:

High-grade microfilaremia

Encephalopathy

A major complication of treatment can be:

Severe encephalopathy/meningoencephalitis

which may be life-threatening.

The source particularly warns about careful supervision when microfilarial density exceeds approximately:

2,000 microfilariae/mL

The risk becomes especially concerning as microfilarial burden increases.

Treatment Principle

Before administering potent microfilaricidal therapy:

Diagnose loiasis

↓

Measure the peripheral microfilarial burden

↓

Assess risk of treatment-associated neurologic complications

↓

Select and administer therapy under appropriate supervision

This is one of the most important clinical principles in managing Loa loa infection.

Additional Treatment

The source lists:

• Ivermectin

• Albendazole

However, ivermectin requires particular caution because patients with very high Loa loa microfilaremia can develop severe or fatal neurologic adverse events following rapid microfilarial killing.

Albendazole has a slower effect on microfilarial levels and has been used in selected situations.

Surgical Removal

When an adult worm is accessible, such as beneath the conjunctiva, it may be:

Surgically extracted

Removal can relieve local symptoms but does not necessarily eliminate other adult worms or circulating microfilariae elsewhere in the body.

Loa loa and Onchocerciasis Treatment

A particularly important practical association is that Loa loa co-infection can complicate treatment programs for:

Onchocerca volvulus

Ivermectin is widely used against onchocerciasis, but a patient with heavy Loa loa microfilaremia may be at risk for severe neurologic reactions after ivermectin.

Therefore, in areas where both parasites occur:

Consider Loa loa burden before ivermectin treatment.

Loa loa vs. Onchocerca volvulus

Loa loa

→ Chrysops deer fly

→ Daytime microfilariae in blood

→ Calabar swellings

→ Eye worm crosses conjunctiva

→ DEC is an important treatment

→ High microfilarial burden creates treatment-related encephalopathy risk

Onchocerca volvulus

→ Blackfly (Simulium)

→ Microfilariae primarily in skin, not peripheral blood

→ Subcutaneous nodules

→ Dermatitis

→ Ocular disease and river blindness

→ Ivermectin is central to treatment

Loa loa vs. Wuchereria bancrofti

Loa loa

→ Chrysops deer fly

→ Diurnal blood periodicity

→ Calabar swelling

→ Subconjunctival adult worm

Wuchereria bancrofti

→ Mosquito vector

→ Classically nocturnal blood periodicity

→ Lymphatic filariasis

→ Lymphedema and elephantiasis

High-Yield Diagnostic Pattern

Central/West Africa

• ●

Chrysops deer fly exposure

• ●

Calabar swellings

• ●

Subconjunctival migrating worm

• ●

Diurnally periodic microfilariae in peripheral blood

→ Loa loa

Exam Essentials

Organism: Loa loa

Type: Filarial nematode

Disease: Loiasis

Common name: African eye worm

Geography: Central and West Africa

Vector: Chrysops deer fly

Major reservoir/host: Humans are important hosts in endemic transmission

Adult worms: Migrate through subcutaneous tissues

Classic swelling: Calabar swelling

Classic ocular manifestation: Adult worm crossing the subconjunctiva

Microfilariae: Circulate in peripheral blood

Periodicity: Diurnal

Best classic blood sampling: Daytime

Diagnosis: Peripheral blood smear, direct visualization/removal of adult worm, supportive serology

Primary source treatment: Diethylcarbamazine (DEC)

Additional source treatments: Ivermectin and albendazole

Major treatment danger: Encephalopathy with high microfilarial burden

Important ivermectin issue: Heavy Loa loa microfilaremia increases the risk of severe neurologic adverse reactions

Key clinical pearl: The classic triad for Loa loa is Central/West African exposure, recurrent Calabar swellings, and a migrating subconjunctival “eye worm.” Microfilariae demonstrate diurnal periodicity, so diagnostic blood should be obtained during the daytime. Always consider the microfilarial burden before microfilaricidal treatment because heavily infected patients can develop life-threatening encephalopathy.

Infectious Disease and Microbiology – Linguatula serrata

Overview

Linguatula serrata is a pentastomid parasite, commonly called the tongue worm, that can occasionally infect humans. Human infection is known as linguatuliasis.

The parasite primarily infects animals, while humans can become accidental hosts. One of its classic clinical presentations is infestation of the nasopharynx, producing a syndrome known as halzoun or marrara syndrome.

Taxonomy

Genus: Linguatula

Species: Linguatula serrata

The source contains the spelling “L. serrate”; the correct species name is:

L. serrata

Microbiologic Characteristics

L. serrata is a:

• Pentastomid parasite

• Commonly called a tongue worm

• Obligate parasite of vertebrate hosts

• Cause of rare zoonotic human infection

Despite the traditional term “tongue worm,” pentastomids are not true helminthic worms in the conventional taxonomic sense. They are highly specialized parasitic arthropods related to crustaceans.

Morphology

The adult parasite has an elongated, flattened appearance that resembles a tongue, accounting for the name:

Tongue worm

The life cycle includes:

Egg → larva/nymph → adult

The nymphal stage is particularly important in human infection.

Incubation Period

The incubation period is:

Not clearly established

For nasopharyngeal disease, symptoms can develop after ingestion of infective stages in contaminated or inadequately prepared animal tissues.

Epidemiology

Human linguatuliasis is uncommon but has been reported more frequently in:

• Middle Eastern regions

• Africa

Cases can also occur elsewhere where the parasite’s animal life cycle is maintained.

Animal Hosts

The parasite has a zoonotic life cycle involving various animals.

The source broadly associates pentastomid parasites with:

• Reptiles

• Birds

• Mammals

For L. serrata specifically, dogs and other canids are particularly important definitive hosts, while herbivorous mammals can serve as intermediate hosts.

Transmission to Humans

Human infection can occur through ingestion of:

Raw or inadequately cooked infected animal tissues

particularly viscera containing nymphal stages.

Exposure to parasite eggs from material contaminated by infected definitive hosts can also produce visceral infection.

Linguatuliasis

Human disease can be divided broadly into:

Nasopharyngeal linguatuliasis

and

Visceral linguatuliasis

The source particularly emphasizes the nasopharyngeal form.

Nasopharyngeal Linguatuliasis

Halzoun or Marrara Syndrome

The classic clinical syndrome is:

Halzoun

also called:

Marrara syndrome

This occurs when immature/nymphal parasites attach to or migrate within the upper respiratory and pharyngeal mucosa.

Clinical Manifestations

Nymphs may lodge in the:

• Nasopharynx

• Pharynx

• Nasal passages

• Upper airway

They can cause:

• Foreign-body sensation

• Nasal or pharyngeal irritation

• Cough

• Sneezing

• Dysphagia

• Throat discomfort

• Nasal obstruction

• Upper-airway obstruction in severe cases

Pathogenesis

The characteristic sequence is:

Ingestion of infected raw/undercooked viscera

↓

Release of nymphal parasite

↓

Attachment to nasopharyngeal mucosa

↓

Inflammation and mechanical irritation

↓

Halzoun syndrome

Visceral Linguatuliasis

Humans may also function as accidental intermediate hosts.

After ingestion of parasite eggs, larvae can penetrate the intestinal wall and migrate into internal organs, where they develop into nymphal forms.

Potential sites include:

• Liver

• Lymph nodes

• Other visceral tissues

Many visceral infections may remain asymptomatic and be discovered incidentally.

Diagnosis

The source lists:

Histologic examination of biopsy tissue

as an important diagnostic method.

Diagnosis may be established by demonstrating characteristic parasite structures in affected tissue.

Direct Identification

In nasopharyngeal disease, diagnosis may also be possible when the parasite is:

Directly visualized and removed

Identification of the recovered organism can establish the diagnosis.

Imaging

Visceral nymphs may eventually undergo degeneration and calcification.

Therefore, chronic visceral linguatuliasis may occasionally be recognized through:

Calcified lesions on imaging

although imaging findings alone are not necessarily specific.

Treatment

The primary treatment described in the source is:

Surgical or mechanical removal

This is especially appropriate for accessible parasites involving the nasopharynx.

Nasopharyngeal Disease

For halzoun:

Locate parasite

↓

Remove mechanically

↓

Relieve mucosal irritation and obstruction

Symptomatic supportive care can be provided as necessary.

Visceral Disease

Asymptomatic visceral infection may not require intervention when lesions are inaccessible and inactive.

Surgical management may be considered when a localized lesion produces significant symptoms or complications.

Prevention

Prevention centers on interrupting foodborne and zoonotic exposure.

Important measures include:

• Thoroughly cooking animal meat and viscera

• Avoiding consumption of raw infected liver or other organs

• Appropriate food hygiene

• Avoiding contamination of food or water with animal feces or secretions

High-Yield Clinical Pattern

Middle East or Africa

• ●

Consumption of raw/undercooked animal viscera

• ●

Sudden nasopharyngeal irritation or obstruction

• ●

Visible tongue-worm nymph

→ Think Linguatula serrata

→ Halzoun syndrome

Linguatula vs. Other Tissue Parasites

Linguatula serrata

→ Pentastomid/tongue worm

→ Raw animal viscera

→ Nasopharyngeal disease

→ Halzoun syndrome

→ Mechanical removal

Gnathostoma spinigerum

→ Nematode

→ Raw/undercooked fish or other intermediate/paratenic hosts

→ Migratory cutaneous swelling

→ Eosinophilia

→ Possible CNS disease

Fasciola hepatica

→ Trematode

→ Aquatic vegetation

→ Hepatic migration followed by biliary disease

→ Eosinophilia common during acute migration

Exam Essentials

Organism: Linguatula serrata

Source correction: “L. serrate” → L. serrata

Common name: Tongue worm

Type: Pentastomid parasite

Taxonomic note: Pentastomids are specialized parasitic arthropods rather than conventional helminthic worms

Distribution: More frequently reported in the Middle East and Africa

Important definitive hosts: Dogs and other canids

Human role: Accidental host

Important exposure: Raw or undercooked animal viscera

Classic disease: Nasopharyngeal linguatuliasis

Classic syndrome: Halzoun (marrara syndrome)

Major symptoms: Nasopharyngeal irritation, foreign-body sensation and possible obstruction

Other form: Visceral linguatuliasis

Diagnosis: Direct parasite identification or histologic examination

Treatment: Mechanical/surgical removal

Prevention: Thorough cooking of meat and viscera

Key clinical pearl: Think of Linguatula serrata when ingestion of raw or undercooked animal viscera is followed by acute nasopharyngeal irritation, foreign-body sensation, or obstruction. This classic presentation is called halzoun (marrara syndrome), and treatment is primarily mechanical removal of the parasite.

Infectious Disease and Microbiology – Leuconostoc Species

Overview

Leuconostoc species are Gram-positive cocci that are uncommon causes of human disease. They have a worldwide distribution and may be confused in the laboratory with Enterococcus species or viridans group streptococci.

Although isolation may occasionally represent contamination or colonization, recovery of Leuconostoc from blood cultures should be evaluated carefully, particularly because true bacteremia and infective endocarditis can occur.

A particularly important microbiologic feature is their intrinsic resistance to vancomycin.

Important Species

The source lists:

• Leuconostoc citreum

• Leuconostoc lactis

• Leuconostoc mesenteroides

• Leuconostoc paramesenteroides

• Other Leuconostoc species

Taxonomy within this group has changed over time, so some organisms found in older literature have subsequently been reassigned.

Microbiologic Characteristics

Leuconostoc species are generally:

• Gram-positive cocci

• Facultatively anaerobic rather than strictly anaerobic

• Catalase-negative

• Non-spore-forming

• Lactic acid-producing organisms

Their appearance and biochemical characteristics can lead to confusion with other catalase-negative Gram-positive cocci.

Laboratory Identification

Leuconostoc may be mistaken for:

Enterococcus species

or:

Viridans group streptococci

Accurate identification is clinically important because the antimicrobial susceptibility pattern differs substantially from that of many other Gram-positive cocci.

Vancomycin Resistance

Major High-Yield Feature

The most important antimicrobial characteristic is:

Intrinsic vancomycin resistance

Therefore:

Gram-positive coccus

• ●

Looks like Enterococcus or viridans streptococcus

• ●

Vancomycin resistant

→ Consider Leuconostoc

Clinical Importance of Vancomycin Resistance

Vancomycin is commonly used empirically for serious Gram-positive infections.

However:

Leuconostoc → intrinsically resistant to vancomycin

Thus, failure to identify the organism correctly can lead to inappropriate antimicrobial treatment.

Incubation Period

The incubation period is:

Unknown

A defined incubation period is generally not clinically useful because invasive disease is rare and frequently occurs opportunistically in patients with significant underlying risk factors.

Epidemiology

Leuconostoc species have a:

Worldwide distribution

They are widely encountered in nature and are particularly associated with:

• Plants

• Vegetables

• Fermented foods

• Dairy and food-production environments

Human invasive infection remains uncommon.

Clinical Significance

The source notes that the clinical significance of Leuconostoc species has historically been uncertain.

Isolation may sometimes represent:

Contamination

However, recovery from a normally sterile site—particularly the bloodstream—should not automatically be dismissed.

Bacteremia

Leuconostoc species have occasionally caused:

Bacteremia

The source particularly identifies cases involving:

• Newborns

• Immunocompromised patients

Risk Factors for Invasive Infection

Reported invasive disease is more likely in patients with factors such as:

• Immunosuppression

• Severe underlying illness

• Neonatal age

• Prolonged hospitalization

• Intravascular catheters

• Disrupted gastrointestinal barriers

• Previous broad-spectrum antimicrobial exposure

Because cases are rare, these associations should be interpreted in the overall clinical context.

Blood Culture Interpretation

When Leuconostoc is recovered from blood, consider:

Contaminant?

versus:

True bacteremia/endovascular infection?

Evidence favoring genuine infection includes:

• Multiple positive blood cultures

• Persistent bacteremia

• Fever or sepsis

• Immunocompromised state

• Intravascular device

• Evidence of infective endocarditis

Infective Endocarditis

Leuconostoc species are a:

Rare cause of infective endocarditis

Persistent bloodstream isolation should therefore raise concern for an endovascular focus.

Endocarditis Evaluation

Possible findings include:

• Persistent fever

• Repeated positive blood cultures

• New or changing cardiac murmur

• Valvular vegetation

• Embolic manifestations

When clinically indicated, echocardiography may be necessary to investigate for valvular infection.

High-Yield Endocarditis Pattern

Persistent blood cultures with Leuconostoc

• ●

Fever

• ●

Cardiac/endovascular findings

→ Evaluate for infective endocarditis

Do not automatically dismiss the isolate as contamination.

Diagnosis

The principal diagnostic method is:

Culture

Depending on the infection, specimens may include:

• Blood cultures

• Catheter-associated specimens

• Tissue or other normally sterile material

Correct species identification is particularly important because of the organism’s vancomycin resistance.

Treatment

Penicillin or Ampicillin

The source recommends:

Penicillin G

or:

Ampicillin

For severe infections, the source recommends:

High-dose intravenous therapy

Additional Treatment Options

The source lists:

• First-generation cephalosporins

• Clindamycin

• Imipenem

Because invasive Leuconostoc infection is uncommon, treatment should ideally be guided by:

Antimicrobial susceptibility testing

particularly in severe or endovascular disease.

Avoid Vancomycin

A central treatment principle is:

Do not rely on vancomycin for Leuconostoc.

The organism is:

Intrinsically resistant to vancomycin

This is not simply an occasional acquired resistance pattern; it is a characteristic property of the genus.

Mechanism of Vancomycin Resistance

Vancomycin normally binds to the:

D-Ala-D-Ala

terminus of peptidoglycan precursors.

Leuconostoc uses altered cell-wall precursors ending in:

D-Ala-D-Lac

which greatly reduces vancomycin binding.

This provides the basis for its characteristic intrinsic glycopeptide resistance.

Treatment Principle

For clinically significant Leuconostoc infection:

Confirm true infection

↓

Correctly identify the organism

↓

Recognize intrinsic vancomycin resistance

↓

Perform susceptibility testing

↓

Use an active agent such as penicillin/ampicillin when susceptible

↓

Evaluate persistent bacteremia for an endovascular source

Leuconostoc vs. Enterococcus

Leuconostoc

→ Gram-positive coccus

→ Catalase-negative

→ May resemble Enterococcus

→ Rare opportunistic pathogen

→ Intrinsically vancomycin resistant

Enterococcus

→ Gram-positive coccus

→ Catalase-negative

→ Common GI flora

→ Common cause of UTI, bacteremia and endocarditis

→ Vancomycin susceptibility varies; acquired VRE mechanisms are clinically important

The distinction is particularly important when a presumed “enterococcus” demonstrates unexpected vancomycin resistance.

High-Yield Clinical Pattern

Immunocompromised or neonatal patient

• ●

Gram-positive cocci in blood

• ●

Organism resembles Enterococcus/viridans streptococcus

• ●

Vancomycin resistance

→ Think Leuconostoc

Exam Essentials

Genus: Leuconostoc

Important species: L. citreum, L. lactis, L. mesenteroides, L. paramesenteroides

Morphology: Gram-positive cocci

Metabolism: Facultatively anaerobic

Catalase: Negative

Distribution: Worldwide

Incubation: Unknown

Clinical significance: Usually low pathogenicity but capable of invasive disease

Important hosts: Newborns and immunocompromised patients

Major invasive infection: Bacteremia

Endovascular infection: Rare endocarditis

Diagnostic method: Culture

Laboratory confusion: Enterococcus and viridans streptococci

Source treatment: Penicillin G or ampicillin

Severe disease: High-dose IV therapy described in source

Additional source treatments: First-generation cephalosporin, clindamycin, imipenem

Major antimicrobial clue: Intrinsic vancomycin resistance

Resistance mechanism: Cell-wall precursor ending in D-Ala-D-Lac

Key clinical pearl: The classic clue for Leuconostoc is an unusual catalase-negative Gram-positive coccus that resembles Enterococcus or viridans streptococci but is intrinsically resistant to vancomycin. When repeatedly isolated from blood, particularly in a newborn or immunocompromised patient, it should be taken seriously and persistent bacteremia should prompt consideration of endocarditis.

Important Species The source lists: • Leuconostoc citreum

• Leuconostoc lactis

• Leuconostoc mesenteroides

• Leuconostoc paramesenteroides

• Other Leuconostoc species Taxonomy within this group has changed over time, so some organisms found in older literature have subsequently been reassigned.

Microbiologic Characteristics Leuconostoc species are generally: • Gram-positive cocci

• Facultatively anaerobic rather than strictly anaerobic

• Catalase-negative

• Non-spore-forming

• Lactic acid-producing organisms Their appearance and biochemical characteristics can lead to confusion with other catalase-negative Gram-positive cocci.

Laboratory Identification Leuconostoc may be mistaken for: Enterococcus species or: Viridans group streptococci Accurate identification is clinically important because the antimicrobial susceptibility pattern differs substantially from that of many other Gram-positive cocci.

Vancomycin Resistance Major High-Yield Feature The most important antimicrobial characteristic is: Intrinsic vancomycin resistance Therefore: Gram-positive coccus  ●  Looks like Enterococcus or viridans streptococcus  ●  Vancomycin resistant → Consider Leuconostoc

Clinical Importance of Vancomycin Resistance Vancomycin is commonly used empirically for serious Gram-positive infections. However: Leuconostoc → intrinsically resistant to vancomycin Thus, failure to identify the organism correctly can lead to inappropriate antimicrobial treatment.

Incubation Period The incubation period is: Unknown A defined incubation period is generally not clinically useful because invasive disease is rare and frequently occurs opportunistically in patients with significant underlying risk factors.

Epidemiology Leuconostoc species have a: Worldwide distribution They are widely encountered in nature and are particularly associated with: • Plants

• Vegetables

• Fermented foods

• Dairy and food-production environments Human invasive infection remains uncommon.

Clinical Significance The source notes that the clinical significance of Leuconostoc species has historically been uncertain. Isolation may sometimes represent: Contamination However, recovery from a normally sterile site—particularly the bloodstream—should not automatically be dismissed.

Bacteremia Leuconostoc species have occasionally caused: Bacteremia The source particularly identifies cases involving: • Newborns

• Immunocompromised patients

Risk Factors for Invasive Infection Reported invasive disease is more likely in patients with factors such as: • Immunosuppression

• Severe underlying illness

• Neonatal age

• Prolonged hospitalization

• Intravascular catheters

• Disrupted gastrointestinal barriers

• Previous broad-spectrum antimicrobial exposure Because cases are rare, these associations should be interpreted in the overall clinical context.

Blood Culture Interpretation When Leuconostoc is recovered from blood, consider: Contaminant? versus: True bacteremia/endovascular infection? Evidence favoring genuine infection includes: • Multiple positive blood cultures

• Persistent bacteremia

• Fever or sepsis

• Immunocompromised state

• Intravascular device

• Evidence of infective endocarditis

Infective Endocarditis Leuconostoc species are a: Rare cause of infective endocarditis Persistent bloodstream isolation should therefore raise concern for an endovascular focus.

Endocarditis Evaluation Possible findings include: • Persistent fever

• Repeated positive blood cultures

• New or changing cardiac murmur

• Valvular vegetation

• Embolic manifestations When clinically indicated, echocardiography may be necessary to investigate for valvular infection.

High-Yield Endocarditis Pattern Persistent blood cultures with Leuconostoc  ●  Fever  ●  Cardiac/endovascular findings → Evaluate for infective endocarditis Do not automatically dismiss the isolate as contamination.

Diagnosis The principal diagnostic method is: Culture Depending on the infection, specimens may include: • Blood cultures

• Catheter-associated specimens

• Tissue or other normally sterile material Correct species identification is particularly important because of the organism’s vancomycin resistance.

Treatment Penicillin or Ampicillin The source recommends: Penicillin G or: Ampicillin For severe infections, the source recommends: High-dose intravenous therapy

Additional Treatment Options The source lists: • First-generation cephalosporins

• Clindamycin

• Imipenem Because invasive Leuconostoc infection is uncommon, treatment should ideally be guided by: Antimicrobial susceptibility testing particularly in severe or endovascular disease.

Avoid Vancomycin A central treatment principle is: Do not rely on vancomycin for Leuconostoc. The organism is: Intrinsically resistant to vancomycin This is not simply an occasional acquired resistance pattern; it is a characteristic property of the genus.

Mechanism of Vancomycin Resistance Vancomycin normally binds to the: D-Ala-D-Ala terminus of peptidoglycan precursors. Leuconostoc uses altered cell-wall precursors ending in: D-Ala-D-Lac which greatly reduces vancomycin binding. This provides the basis for its characteristic intrinsic glycopeptide resistance.

Treatment Principle For clinically significant Leuconostoc infection: Confirm true infection ↓ Correctly identify the organism ↓ Recognize intrinsic vancomycin resistance ↓ Perform susceptibility testing ↓ Use an active agent such as penicillin/ampicillin when susceptible ↓ Evaluate persistent bacteremia for an endovascular source

Leuconostoc vs. Enterococcus Leuconostoc → Gram-positive coccus

→ Catalase-negative

→ May resemble Enterococcus

→ Rare opportunistic pathogen

→ Intrinsically vancomycin resistant Enterococcus → Gram-positive coccus

→ Catalase-negative

→ Common GI flora

→ Common cause of UTI, bacteremia and endocarditis

→ Vancomycin susceptibility varies; acquired VRE mechanisms are clinically important The distinction is particularly important when a presumed “enterococcus” demonstrates unexpected vancomycin resistance.

High-Yield Clinical Pattern Immunocompromised or neonatal patient  ●  Gram-positive cocci in blood  ●  Organism resembles Enterococcus/viridans streptococcus  ●  Vancomycin resistance → Think Leuconostoc

Exam Essentials Genus: Leuconostoc

Important species: L. citreum, L. lactis, L. mesenteroides, L. paramesenteroides

Morphology: Gram-positive cocci

Metabolism: Facultatively anaerobic

Catalase: Negative

Distribution: Worldwide

Incubation: Unknown

Clinical significance: Usually low pathogenicity but capable of invasive disease

Important hosts: Newborns and immunocompromised patients

Major invasive infection: Bacteremia

Endovascular infection: Rare endocarditis

Diagnostic method: Culture

Laboratory confusion: Enterococcus and viridans streptococci

Source treatment: Penicillin G or ampicillin

Severe disease: High-dose IV therapy described in source

Additional source treatments: First-generation cephalosporin, clindamycin, imipenem

Major antimicrobial clue: Intrinsic vancomycin resistance

Resistance mechanism: Cell-wall precursor ending in D-Ala-D-Lac

Key clinical pearl: The classic clue for Leuconostoc is an unusual catalase-negative Gram-positive coccus that resembles Enterococcus or viridans streptococci but is intrinsically resistant to vancomycin. When repeatedly isolated from blood, particularly in a newborn or immunocompromised patient, it should be taken seriously and persistent bacteremia should prompt consideration of endocarditis.

Infectious Disease and Microbiology – Balamuthia mandrillaris

Overview

Balamuthia mandrillaris is a free-living amoeba that causes a rare but extremely serious central nervous system infection known as granulomatous amebic encephalitis (GAE).

Older literature referred to the organism as a leptomyxid amoeba or “leptomyxid species.” Human infection is uncommon but occurs worldwide and is frequently recognized only at an advanced stage or, historically, postmortem.

⸻

Taxonomy

Current name: Balamuthia mandrillaris

Older terminology: Leptomyxid amoeba

Other medically important free-living amoebae include:

• Naegleria fowleri

• Acanthamoeba species

These organisms can all involve the CNS but differ substantially in their epidemiology and clinical presentation.

⸻

Microbiologic Characteristics

B. mandrillaris is a:

• Free-living amoeba

• Environmental organism

• Protozoan pathogen

• Cause of subacute or chronic granulomatous CNS infection

It exists primarily in:

Trophozoite and cyst forms

Both forms may be demonstrated in infected tissue.

⸻

Environmental Reservoir

Balamuthia is associated particularly with:

Soil and dust

Unlike many conventional infectious agents, it does not require a human host to complete its normal environmental existence.

⸻

Transmission

Human infection is thought to occur primarily when the organism enters through:

Broken or traumatized skin

or possibly through:

Inhalation into the respiratory tract

The organism may subsequently disseminate hematogenously to the:

Central nervous system

⸻

Incubation Period

The precise incubation period is:

Unknown

Disease typically evolves much more slowly than the rapidly progressive meningoencephalitis caused by Naegleria fowleri.

⸻

Epidemiology

Balamuthia mandrillaris infection is:

• Worldwide

• Extremely rare

• Frequently fatal

• Capable of affecting both immunocompromised and immunocompetent individuals

Thus, absence of obvious immunosuppression does not exclude balamuthiasis.

⸻

Granulomatous Amebic Encephalitis

Major Infection

The major manifestation is:

Granulomatous amebic encephalitis (GAE)

This is a progressive inflammatory and destructive infection of the brain.

⸻

Clinical Course

Unlike the explosive course of Naegleria infection, Balamuthia GAE generally has a:

Subacute to chronic course

Symptoms can progress over:

Weeks to months

before severe neurologic deterioration occurs.

⸻

Neurologic Manifestations

Patients may develop:

• Headache

• Fever

• Altered mental status

• Behavioral or personality changes

• Seizures

• Focal neurologic deficits

• Ataxia

• Cranial nerve abnormalities

• Progressive loss of consciousness

The nonspecific presentation can make early diagnosis difficult.

⸻

Cutaneous Disease

An important clue preceding CNS disease can be:

Chronic skin lesions

These may appear before neurologic manifestations and can provide an opportunity for earlier recognition and biopsy.

Skin lesions may occur particularly on the:

• Face

• Central facial region

• Extremities

⸻

High-Yield Clinical Pattern

Chronic unusual skin lesion

Weeks to months later

Progressive neurologic symptoms

Brain lesions/encephalitis

→ Consider Balamuthia mandrillaris

⸻

Diagnosis

The source lists:

CSF evaluation

as part of the diagnostic assessment.

However, definitive diagnosis can be challenging and may require examination of:

• Brain tissue

• Skin biopsy specimens

• CSF

• Other involved tissue

⸻

Immunologic Methods

The source describes:

• Direct immunofluorescence

• Immunoblot

These techniques can help distinguish Balamuthia from other free-living amoebae.

⸻

Molecular Diagnosis

Molecular methods such as:

PCR

can also be used to identify Balamuthia DNA in appropriate clinical specimens.

Because the infection is rare and difficult to recognize, specialized laboratory testing is often necessary.

⸻

Histopathology

Tissue examination may demonstrate:

Amebic trophozoites and cysts

within areas of granulomatous inflammation and tissue destruction.

Recognition of these organisms in brain or skin biopsy material can be critical for diagnosis.

⸻

CSF Findings

CSF abnormalities may resemble other forms of chronic meningoencephalitis and can include:

• Pleocytosis

• Elevated protein

• Reduced or normal glucose

Routine CSF studies alone are generally insufficient to establish the specific diagnosis.

⸻

Imaging

Brain imaging may reveal:

Multiple space-occupying or enhancing lesions

which can mimic:

• Brain tumors

• Abscesses

• Tuberculosis

• Fungal infections

• Other inflammatory CNS diseases

Therefore, the diagnosis requires a high index of suspicion.

⸻

Prognosis

Historically, the prognosis has been:

Very poor

The source notes that many patients were diagnosed:

Postmortem

because of the difficulty of recognizing the infection before advanced neurologic disease developed.

⸻

Treatment

Important Update to the Source

The source states:

“There is no known effective treatment.”

This reflects the historically extremely poor prognosis, but it is too absolute for current clinical understanding.

There is no single reliably curative standardized drug, but rare survivors have been reported after prolonged multidrug therapy.

Management therefore requires expert consultation and combination treatment rather than assuming therapy is universally futile.

⸻

Treatment Principle

Treatment of confirmed or strongly suspected Balamuthia infection generally involves:

Multiple anti-amoebic/antimicrobial agents

used in combination for prolonged periods.

Because the disease is extremely rare, the optimal regimen is not firmly established, and treatment should involve infectious-disease specialists and public-health/reference experts.

⸻

Comparison of Free-Living Amoebae

Balamuthia mandrillaris

→ Soil/dust exposure

→ Skin or respiratory entry

→ Granulomatous amebic encephalitis

→ Subacute/chronic progression

→ Can affect immunocompetent patients

→ Cutaneous lesions may precede CNS disease

Acanthamoeba species

→ Environmental free-living amoeba

→ Keratitis, especially associated with contact lenses

→ Granulomatous amebic encephalitis, particularly in immunocompromised patients

→ Cutaneous disease can occur

Naegleria fowleri

→ Warm freshwater

→ Water enters the nose

→ Migrates through the cribriform plate

→ Primary amebic meningoencephalitis (PAM)

→ Rapid, fulminant disease over days

⸻

High-Yield Balamuthia vs. Naegleria

Balamuthia

→ Soil exposure

→ GAE

→ Weeks to months

→ Possible preceding skin lesion

Naegleria

→ Warm freshwater exposure

→ Nasal entry

→ PAM

→ Rapid progression over days

This difference in tempo is particularly useful diagnostically.

⸻

High-Yield Clinical Pattern

Free-living amoeba

Progressive encephalitis over weeks to months

Possible chronic skin lesion

Granulomatous brain disease

→ Think Balamuthia mandrillaris

⸻

Exam Essentials

Organism: Balamuthia mandrillaris

Older designation: Leptomyxid amoeba

Type: Free-living amoeba

Forms: Trophozoite and cyst

Distribution: Worldwide

Frequency: Extremely rare

Environmental association: Soil and dust

Incubation: Unknown

Possible entry: Skin or respiratory tract

Major disease: Granulomatous amebic encephalitis (GAE)

Clinical course: Subacute/chronic—weeks to months

Important clue: Cutaneous lesions may precede neurologic disease

Diagnosis: Tissue examination, immunofluorescence, molecular testing such as PCR, and supportive CSF evaluation

Historical problem: Many cases diagnosed postmortem

Treatment: No single reliably effective standardized therapy; multidrug regimens have produced rare survivors

Prognosis: Very poor

⸻

Key clinical pearl: Think of Balamuthia mandrillaris when progressive granulomatous encephalitis develops over weeks to months, particularly when preceded by an unexplained chronic skin lesion. Unlike Naegleria fowleri, which causes rapidly fulminant primary amebic meningoencephalitis after warm-freshwater nasal exposure, Balamuthia typically produces a slower granulomatous CNS disease.